针对瘤突变的个性化癌症疫苗:从小鼠到人类建立证据
Edward F Fritsch1, Patrick A Ott1,2,3
1Department of Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts.
Cancer research
|April 1, 2024
概括
针对瘤突变的个性化癌症疫苗正在迅速发展. 这些疫苗刺激T细胞对新抗原的反应,在黑色素瘤和其他癌症中显示出希望.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 基因组学就是基因组学.
背景情况:
- 针对瘤特定突变的个性化疫苗是癌症治疗中快速发展的领域.
- 该策略涉及刺激T细胞对来自单个瘤突变的新抗原的反应.
研究的目的:
- 审查个性化新抗原疫苗的开发和进展情况.
- 突出这些疫苗在癌症治疗中的潜力.
主要方法:
- 使用基因组或外基因组测序来识别瘤突变.
- 采用突变调用和表位预测来选择新抗原.
- 为个别患者制造定制的长或RNA疫苗.
主要成果:
- 早期的研究表明,包含新抗原的长疫苗可以在临床前模型 (例如,小鼠B16F10黑色素瘤) 中引起强大的免疫反应和抗瘤活性.
- 随后在黑色素瘤患者中进行的临床试验表明,这些个性化疫苗是安全和免疫原性的.
- 目前正在进行的注册试验正在评估针对黑色素瘤和其他恶性瘤的个性化RNA新抗原疫苗.
结论:
- 个性化新抗原疫苗代表了瘤学中一个有前途的治疗策略.
- 由于疫苗介导的临床疗效的证据不断积累,该领域已经出现了显著的加速.
- 进一步的临床试验至关重要,以确定这些针对各种癌症的个性化疫苗的全部潜力.
相关概念视频
Mouse Models of Cancer Study
5.5K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
5.5K
Cancer Vaccines
363
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
363
Tumor Immunotherapy
523
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
523
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K


